Comparative analysis of N-acetyltransferase 2 genotyping results among patients with newly diagnosed pulmonary tuberculosis residing in the Sakha Republic (Yakutia)

Comparative analysis of N-acetyltransferase 2 genotyping results among patients with newly diagnosed pulmonary tuberculosis residing in the Sakha Republic (Yakutia)

Aim. To assess the variability of the NAT2 gene and to comparatively analyze the prevalence of NAT2 polymorphisms and acetylation types among Yakut and Russian patients newly diagnosed with pulmonary tuberculosis (TB), permanently residing in the Sakha Republic (Yakutia).Materials and methods. The s...

Full description

Bibliographic Details
Main Authors:	N. M. Krasnova, E. N. Efremova, A. A. Egorova, O. I. Filippova, Y. V. Chertovskikh, Z. A. Rudykh, E. A. Alekseeva, T. E. Tatarinova, D. A. Sokorutov, N. S. Val, M. K. Vinokurova, A. F. Karvchenko, A. I. Vengerovskii, D. A. Sychev
Format:	Article
Language:	English
Published:	Siberian State Medical University (Tomsk) 2021-01-01
Series:	Бюллетень сибирской медицины
Subjects:	якуты русские туберкулез изониазид фармакогенетика полиморфизм nat2 медленный быстрый промежуточный тип ацетилирования
Online Access:	https://bulletin.ssmu.ru/jour/article/view/4156

Similar Items

EXPERIMENTAL RATIONALE FOR THE USE OF ROPRENE TO PREVENT ISONIAZID-INDUCED LIVER DAMAGES
by: G. N. Mozhokina, et al.
Published: (2014-07-01)

Biotransformation enzymes for xenobiotics and personalization of treatment regimens for tuberculosis patients
by: G. N. Mozhokina, et al.
Published: (2016-04-01)

Organo-protective effects of quinapril: pharmacogenetic aspects
by: D. A. Sychev, et al.
Published: (2011-04-01)

Роль генетического полиморфизма в онкологии
Published: (2018-06-01)

LANGUAGE AND COGNITION: REGIONAL PERSPECTIVE
by: OLGA V BALYASNIKOVA, et al.
Published: (2018-12-01)

DEVELOPMENT OF THE COMPOSITION AND TECHNOLOGY FOR THE PREPARATION OF THE DRAGEE WITH IZONIAZIDE AND OILOXACIN
by: Yu. V. Shikova, et al.
Published: (2019-01-01)

Heterogeneity of Mycobacterium tuberculosis drug resistance in respect of pharmacokinetics of anti-tuberculosis drugs as a basis for individual treatment regimen
by: S. A. Popov, et al.
Published: (2015-04-01)

Role of genetic factors in the development of metabolic and immune response in the cases of acute respiratory infections complicated by pneumonia in the conditions of the far north in various ethnic groups
by: V. V. Ivanova, et al.
Published: (2014-09-01)

PREDICTORS OF LONG-TERM PROGNOSIS OF MYOCARDIAL INFARCTION: FOCUS ON THE PHARMACOKINETICS
by: M. V. Solodun, et al.
Published: (2016-05-01)

Structural features of creative abilities among university students with reçective and impulsive cognitive styles
by: Irina А. Kibal'chenko, et al.

ASPECTS OF LIPID-LOWERING THERAPY WITH ATORVASTATIN IN PATIENTS WITH MYOCARDIAL INFARCTION FROM THE PERSPECTIVE OF PERSONALIZED MEDICINE
by: M. V. Solodun, et al.
Published: (2015-09-01)

GENETIC PREDICTORS OF SEVERITY AND EFFICACY OF COVID-19 PHARMACOTHERAPY
by: I. N. Shishimorov, et al.
Published: (2021-08-01)

Association of CYP3A5 (6986A>G) gene polymorphism with the effectiveness of anti-inflammatory therapy in children with bronchial asthma
by: A. K. Zastrozhina, et al.
Published: (2019-06-01)

EFFECTIVENESS OF COMBINATION OF ISONIAZID AND SILVER NANOPARTICLES IN THE TREATMENT OF EXPERIMENTAL TUBERCULOSIS
by: A. V. Zаkhаrov, et al.
Published: (2017-06-01)

The efficacy of the combination drug of hydroxymethylquinoxalinedioxide + isoniazid lyophilisate in the treatment of bronchial tuberculosis
by: A. A. Stаrshinovа
Published: (2019-05-01)

MODERN IDEAS OF “SLOW SLEEP” AND “REM-SLEEP” AND THEIR ROLE IN PATHOGENESIS OF ALZHEIMER’S DISEASE (REVIEW OF LITERATURE)
by: I. M. Madaeva, et al.
Published: (2017-07-01)

Clinical pharmacogenetics of angiotensin II receptor blockers: new perspectives of pharmacotherapy individualization
by: D. A. Sychev, et al.
Published: (2006-04-01)

Chitosan and deoxy-starch as polymeric matrixes for immobilization of bioactive components
by: V. A. Kuznetsov, et al.
Published: (2009-06-01)

Lingual disposition of Sakha in education in context of modern extralinguistic realities (based on polls in Yakutsk)
by: Nina I. Ivanova
Published: (2018-03-01)

Parameters of hepatotoxic reactions caused by the combination of first line anti-tuberculosis drugs in rats with different acetylation phenotypes
by: G. N. Mozhokina, et al.
Published: (2020-08-01)

Yakut values at the beginning of the 21st century
by: Uliana A. Vinokurova
Published: (2017-09-01)

Yakut algys in the spotlight of folklore traditions of Turkic and Mongol people of Siberia
by: Tamara G. Basangova
Published: (2015-11-01)

CYTOKINE GENE POLYMORPHISMS AS PREDICTORS OF CHRONIC PAIN SYNDROME IN ONCOLOGY
by: O. P. Bobrova, et al.
Published: (2017-11-01)

Efficiency and safety of pharmacotherapy for postoperative pain in cardiac surgery
by: D. A. Sychev, et al.
Published: (2021-05-01)

Epithelioid trophoblastic tumor: Clinical presentation, diagnosis, and treatment
by: D. A. Lisayev, et al.
Published: (2014-08-01)

Prevalence of mutations in Mycobacterium tuberculosis genes coding resistance to isoniazid and rifampicin in tuberculosis patients from different age groups
by: T. Yu. Salina, et al.
Published: (2019-05-01)

PHARMACOGENETIC BASES OF INDIVIDUAL SENSITIVITY AND PERSONALIZED ADMINISTRATION OF ANTIPLATELET THERAPY IN DIFFERENT ETHNIC GROUPS
by: B. I. Kantemirova, et al.
Published: (2021-05-01)

APPLIED ASPECTS OF SLCO1B1 PHARMACOGENETIC TESTING FOR PREDICTING OF STATIN-INDUCED MYOPATHY AND PERSONALIZATION OF STATINS THERAPY
by: D. A. Sychev, et al.
Published: (2015-09-01)

POTENTIAL OF PHARMACOGENETICS IN THE CORRECTION OF ANTICOAGULANT THERAPY AMONG PATIENT WITH PROSTHETIC HEART VALVES
by: I. Yu. Zhuravleva, et al.
Published: (2013-06-01)

EFFECTIVENESS OF REAL-TIME PCR FOR EXPRESS FIRST LINE DRUG SUSCEPTIBILITY TESTING OF TUBERCULOUS MYCOBACTERIA USING SPUTUM SAMPLES AND SURGICAL SPECIMENS OF LUNG TISSUE
by: Yu. S. Alyapkina, et al.
Published: (2019-01-01)

THE SIGNIFICANCE OF PHARMACOGENETIC CYP2C19 TESTING FOR PERSONALIZATION OF THE ANTIPLATELET THERAPY IN CARDIOLOGY PRACTICE
by: K. B. Mirzaev, et al.
Published: (2015-09-01)

Клиническая фармакогенетика: тернистый путь внедрения в клиническую практику
Published: (2018-06-01)

Fast <i>L</i><sup>1 </sup>Gauss Transforms for Edge-Aware Image Filtering
by: D. R. Bashkirova, et al.
Published: (2018-10-01)

The pharmacogenetics antiepileptic drugs
by: N. A. Shnayder, et al.
Published: (2008-12-01)

PHARMACOGENETIC TESTING OPPORTUNITIES IN CARDIOLOGY BASED ON EXOME SEQUENCING
by: N. V. Shcherbakova, et al.
Published: (2015-09-01)

Determination of the Variable Density of the Intermediate Layer within the Gubakha Area (Permskiy Krai)
by: A. P. Shelikhov
Published: (2022-12-01)

GENETIC FACTORS INFLUENCING THE EFFECTIVENESS AND SAFETY OF LONG-TERM ANTICOAGULANT THERAPY
by: T. V. Burkova, et al.
Published: (2013-06-01)

The importance of pharmacogenetic research for optimization of antihypertensive treatment
by: O V Shevchenko, et al.
Published: (2012-09-01)

Генетические маркеры риска развития спектра метаболических нарушений при применении антипсихотиков второй генерации
by: Мазо, Г.Э., et al.
Published: (2017-12-01)

Stenting and cell technologies in the treatment of atherosclerotic renovascular hypertension Part 3. Some genetic, pharmacological, and radio-ecological features of malignant renovascular hypertension
by: A. N. Kharlamov, et al.
Published: (2008-12-01)